Stent Thrombosis : Incidence, Predictors and New Technologies

Abstract EN

Some concerns have been raised regarding the risk of late and very late stent thrombosis (ST) following drug-eluting stent implantation.

Despite remaining an uncommon complication of percutaneous coronary intervention, when ST occurs, it can be catastrophic to the individual, commonly presenting as acute ST elevation myocardial infarction or sudden cardiac death.

The incidence and predictors of ST have been reported in the literature and the role of dual antiplatelet therapies in the avoidance of such a complication remains vital.

Ongoing studies are assessing the role of these therapies including platelet reactivity testing, genetic testing and optimum duration of therapy.

In addition, newer polymer-free and bioabsorbable stents are under investigation in the quest to potentially minimise the risk of ST.